Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Chima Matsumoto"'
Autor:
Osamu Ohmori, Kazuko Shimizu, Shinichi Sakata, Yuko Fukunaka, Takahiro Shinkai, Rudi Hwang, Kensuke Utsunomiya, Chima Matsumoto, Yui Naoe, Hiroko Hori, Jun Nakamura
Publikováno v:
NeuroMolecular Medicine. 9:292-297
The underlying pathophysiology of primary polydipsia in schizophrenia (SCZ) is poorly understood. Our previous study, however, suggested that this condition may have a genetic component [Shinkai et al 2003 Am J Med Genet 119B 7-12]. Orexins, also cal
Autor:
Rudi Hwang, Albert H.C. Wong, Gwyneth Zai, Gregory W.H. Wong, Joseph Trakalo, Chima Matsumoto, Matthew B. Lanktree, Takahiro Shinkai, Osamu Ohmori, Fabio Macciardi, James L. Kennedy, Daniel J. Müller, Tricia Sicard, Jun Nakamura, Sajid A. Shaikh, Natalia Potapova, Nicole King, Vincenzo De Luca, Hiroko Hori
Publikováno v:
NeuroMolecular Medicine. 9:169-177
A number of linkage studies have previously implicated the region of chromosome 13q34 in schizophrenia. Chumakov and colleagues (2002) identified a gene complex called G72 (now termed D-amino acid oxidase activator: DAOA)/G30 in this region and perfo
Autor:
Yasuhisa Yamada, Nobuhisa Ueda, Chima Matsumoto, Reiji Yoshimura, Osamu Ohmori, Shingo Kakihara, Koji Shinkai, Kyoko Kaji, Makiko Goto, Jun Nakamura
Publikováno v:
International Clinical Psychopharmacology. 20:71-78
In the present study, we examined the relationships between plasma concentrations of risperidone and clinical responses, extrapyramidal symptoms, plasma levels of cotinine and caffeine, or cytochrome (cyp)2D6 genotypes. In addition, we also investiga
Publikováno v:
Psychiatric Genetics. 14:209-213
OBJECTIVE Recent studies have revealed positive associations between tardive dyskinesia (TD) and genetic polymorphisms of several cytochrome P450 (CYP) subfamilies that are involved in pharmacokinetic process of antipsychotic drugs. In the present st
Autor:
Gregory W.H. Wong, Osamu Ohmori, Paul D. Arnold, Sajid A. Shaikh, Nicole King, James L. Kennedy, Takahiro Shinkai, Albert H.C. Wong, Gwyneth Zai, Natalia Potapova, Chima Matsumoto, Joseph Trakalo, Rudi Hwang, Jun Nakamura, Hiroko Hori, Vincenzo De Luca
Publikováno v:
Psychiatric Genetics. 14:177-180
Oxidative stress such as free radical-mediated neuronal dysfunction may be involved in the pathophysiology of schizophrenia. The human glutathione peroxidase (GPX1) is a selenium-dependent enzyme, which plays an important role in the detoxification o
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27:581-586
Interindividual genetic profile differences related to antipsychotic drug therapy may be determined based on molecular genetic studies of the pathogenesis of schizophrenia and studies of antipsychotic drug responses (therapeutic as well as adverse re
Publikováno v:
Psychiatry Research. 118:235-239
NAD(P)H: quinone oxidoreductase (NQO1), an obligate two-electron reductase of quinones, prevents their participation in redox cycling and subsequent generation of reactive oxygen species (ROS). Reduced or negative activity of NQO1 would lead to an ex
Publikováno v:
Neuroscience Letters. 321:165-168
An increasing amount of evidence suggests a possible implication of oxidative stress in the pathophysiology of schizophrenia. Oxidized low-density lipoproteins (oxLDL) have been reported to be capable of eliciting neurocytotoxicity. On the other hand
Autor:
Osamu Ohmori, Kensuke Utsunomiya, Yui Naoe, Kazuko Shimizu, Jun Nakamura, Takahiro Shinkai, Shinichi Sakata, Hiroko Hori, Rudi Hwang, Chima Matsumoto, Yuko Fukunaka
Publikováno v:
Neuroscience letters. 415(2)
Brain-derived neurotrophic factor (BDNF) is a nerve growth factor that plays an important role in the development and maintenance of adult neurons and is important regulator of synaptic plasticity in human brain. It has been reported that there are a
Autor:
Vincenzo De Luca, Takahiro Shinkai, Jun Nakamura, Rudi Hwang, Hiroko Hori, Osamu Ohmori, Chima Matsumoto, James L. Kennedy
Publikováno v:
Neuromolecular medicine. 8(3)
The underlying pathophysiology of polydipsia in schizophernia is poorly understood. Several studies, however, have suggested that there might be a genetic predisposition to polydipsia. In the present study, using a case-control sample that is indepen